Clinical Trial Update: Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating mexiletine hydrochloride for spinal and bulbar muscular atrophy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal and Bulbar Muscular Atrophy

Drugs mentioned

• Mexiletine hydrochloride (mexiletine hydrochloride)

Snippet

Sponsor: Masahisa Katsuno | Conditions: Spinal and Bulbar Muscular Atrophy | Phase 2, Phase 3 | Status: RECRUITING